NAS10029,447+1.73%S&P7,638+1.14%GOLD$4,406+0.14%BTC$77,436VIX15.44−12.82%live tape · as of 11:00 UTC
The Screen · Industrials · Electrical Equipment & Parts
Forgent Power Solutions, Inc.
FPS · the NYSE · USD · Market cap $9.4B · 2,000 employees
Forgent Power Solutions, Inc designs and manufactures electrical distribution equipment used in data centers, the power grid and energy-intensive industrial facilities.
Screened 2026-09-09 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its distribution label.
Forgent Power Solutions, Inc. holds its Distribution at $30.99. Elevated stress, defensive posture warranted, held for 1 days.
As held on the ledger · 2026-09-09
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 1 days
Price at the screen
$30.99
Valuation
1,549.50 trailing · 26.59 forward price to earnings
Values screen
PASS· score 98.0
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
4.64%
Below 33%
Interest-bearing debt is just 4.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.69%
Below 33%
Cash held in interest-bearing accounts and securities is 0.7% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OVERVALUED: it trades at roughly a 34% discount to our $41.66 fair value, weak competitive moat, 103.40% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 34.4% margin of safety to the base estimate.
Third-party analyst targets: 10 covering, consensus Strong Buy. The average target sits +94% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Power gear for data centres, priced for perfection
Picture every new data hall or grid upgrade needing transfer switches and generator cabinets. Forgent supplies that kit and revenue is doubling, yet the shares trade at 34 times forward earnings with just a 2 percent profit margin and a weak moat.
We pass. The modest discount to our fair value of 41.69 still leaves the business expensive once you strip away the hype around data-centre spend, and the thin margins give little room if growth slows.
Analysts see 60 dollars ahead, but that target assumes the current cycle lasts and margins expand sharply. History shows electrical-equipment makers rarely sustain those multiples when orders normalise. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
FPS trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-15Markdown$30.99+0.0%Entry 20
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 63%. The street (10 analysts) rates it strong buy, with a mean price target of $56. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-14Markdown$30.99+0.0%Entry 19
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 63%. The street (10 analysts) rates it strong buy, with a mean price target of $56. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-13Markdown$30.99+0.0%Entry 18
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 63%. The street (10 analysts) rates it strong buy, with a mean price target of $56. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-12Markdown$30.99+0.0%Entry 17
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 63%. The street (10 analysts) rates it strong buy, with a mean price target of $56. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-11Markdown$30.99+0.0%Entry 16
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 63%. The street (10 analysts) rates it strong buy, with a mean price target of $56. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-10Markdown$30.99-6.6%Entry 15
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.6% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 63%. The street (10 analysts) rates it strong buy, with a mean price target of $56. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-09Markdown$33.18+0.0%Entry 14
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 63%. The street (10 analysts) rates it strong buy, with a mean price target of $56. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-08Markdown$33.18+0.0%Entry 13
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 63%. The street (10 analysts) rates it strong buy, with a mean price target of $56. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-02Markdown$33.18+0.0%Entry 12
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 63%. The street (10 analysts) rates it strong buy, with a mean price target of $56. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-01Markdown$33.18+0.0%Entry 11
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Our forward projection puts the odds of a 10% gain over the next month near 63%. The street (10 analysts) rates it strong buy, with a mean price target of $56. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
